Exhibit 2:
Unmatched Visits | Matched Visits | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
DTC Telemedicine | PCP | Urgent Care | DTC Telemedicine | PCP | Urgent Care | |||||||
Overall (N) | 39,974 | 1,084,056 | 212,837 | 38,839 | 942,613 | 186,016 | ||||||
Any Antibiotic Usea | 20,839 | 52 | 544,105 | 50*** | 113,769 | 53*** | 20,231 | 52 | 497,941 | 53** | 105,048 | 56*** |
Broad-Spectrum Antibiotics Useb | 10,932 | 27 | 302,020 | 28* | 54,829 | 26*** | 10,627 | 27 | 273,628 | 29*** | 52,985 | 28*** |
Guideline-Concordant Antibiotic Managementc | 24,767 | 62 | 660,582 | 61*** | 128,731 | 60*** | 24,055 | 62 | 568,949 | 60*** | 110,095 | 59*** |
Source: Authors’ analysis of data from 2015-2016 claims from a large national insurer.
Notes: Abbreviations: DTC, direct to consumer; PCP, primary care provider.
Visits with antibiotic use include those categorized as guideline-concordant use, guideline non-concordant use, and unnecessary antibiotic use.
Broad-spectrum antibiotics were defined as macrolides (excluding erythromycin), fluoroquinolones, and non-first-generation cephalosporins.
Visits with guideline-concordant antibiotic management include those categorized as guideline-concordant antibiotic use, guideline-concordant non-use of antibiotics, or, for visits with a diagnosis of acute otitis media or sinusitis, no antibiotic use. Hypothesis testing performed using chi-square tests, comparing DTC telemedicine visits to PCP visits and to urgent care visits
p<0.05;
p<0.01;
p<0.001